Pharmacy

US Marshals, at the request of the US Food and Drug Administration (FDA), recently seized more than $6 million in products distributed by Triad   Group, Inc, at the company's facility in Hartland, Wis.

Triad Group and H & P Industries are owned and managed by the same parties. Several drug products were seized, which included povidone-iodine and benzalkonium chloride antiseptic products, cough and cold products, nasal sprays, suppositories, medicated wipes, antifungal creams, haemorrhoidal wipes, in-process drugproducts and raw materials.

The action was taken due to the continued failure of Triad Group and H & P Industries to comply with the FDA's current Good Manufacturing Practice (cGMP) regulations, which are   intended to assure the safety, quality and purity of manufactured drugs. Through this seizure, FDA seeks to prevent the company from distributing products that were manufactured in violation of federally mandated manufacturing requirements.

Dara Corrigan, Associate Commissioner for Regulatory Affairs, FDA, said, "We took this action to stop Triad from continuing to distribute products, which may pose a risk to public health."